ESR1 and breast cancer: In order to investigate if the changes in gene expression in ER+ breast cancer during the menstrual cycle we report here could predict the antiproliferative response to ovarian ablation we correlated the change in AvERG between W1 and W2 or W3 with the response to OvX in samples from the Vietnamese study.17 Only a very weak correlation was observed.